IUCD Complication Clinical Trial
Official title:
Adjuvant Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol for Induction of Abortion in First-trimester Missed Miscarriage: A Randomized Controlled Trial
The primary endpoint was the success rate of adjuvant isonicotinic acid hydrazide (INH) and misoprostol versus misoprostol alone for medical termination of first-trimester pregnancy.
According to the American college of obstetricians and gynecologists (2005), medical abortion
is an acceptable alternative for surgical procedures in pregnant women with gestational age
of less than 10 weeks based on the last menstrual period
Oral or vaginal misoprostol causes complete abortion in almost 85% of cases within seven days
before the 12th week
Adjuvant isonicotinic acid hydrazide (INH) administration with misoprostol raises the rate of
complete abortion
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04517890 -
Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System
|
N/A | |
| Completed |
NCT04500015 -
Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion
|
Phase 4 | |
| Completed |
NCT04499989 -
Vaginal Isonicotinic Acid Hydrazide (INH) Administration Prior to T380A Intrauterine Device Insertion
|
Phase 4 | |
| Not yet recruiting |
NCT04505917 -
Vaginal Misoprostol and Dinoprostone Prior to Copper Intrauterine Device Insertion in Women
|
N/A | |
| Not yet recruiting |
NCT04505943 -
Vaginal Misoprostol and Dinoprostone and Isonicotinic Acid Hydrazide Prior to Copper Intrauterine Device Insertion
|
N/A | |
| Completed |
NCT04505657 -
Lidocaine Spray Plus Oral Celecoxib for Pain Control During Hysterosalpingography
|
N/A | |
| Completed |
NCT04500028 -
Vaginal Isonicotinic Acid Hydrazide Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System
|
Phase 4 |